Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patricia Urbas
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Gene Regulatory and Clinical Effects of Interferon Β in Patients With Metastatic Melanoma: A Phase II Trial
Journal of Interferon and Cytokine Research
Medicine
Virology
Immunology
Cell Biology
Electrochemotherapy Associated With Calcium Electroporation in Metastatic Feline Cutaneous Malignant Melanoma
Acta Scientiae Veterinariae
Veterinary
Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers
Oncologist
Cancer Research
Medicine
Oncology
A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
